Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022

インドのペプチド及びヘパリン市場予測(~2022年)

◆タイトル:Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022
◆商品コード:MAM-PH5511
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年8月21日
◆ページ数:77
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:インド
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD7,150 ⇒換算¥765,050見積依頼/購入/質問フォーム
Multi User (Five User)USD8,500 ⇒換算¥909,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD9,650 ⇒換算¥1,032,550見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"インドのペプチド及びヘパリン市場予測(~2022年)"について調査・分析し、イントロダクション、市場概観、市場の動態、種類別分析、用途別分析、市場規模及び予測、市場シェア分析、主要企業(ベンダー)分析等の情報をお届けいたします。

The Indian peptides market is expected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%. Increasing prevalence of chronic diseases such as diabetes, cancer, and osteoporosis and favorable government policies for the pharmaceutical sector are expected to drive the growth of this market.
The Indian peptides market is segmented by type and application. By type, the Indian peptides market is segmented into calcitonin-salmon, glucagon, insulin, leuprolide acetate, octreotide acetate, teriparatide, exenatide, bivalirudin, glatiramer acetate, eptifibatide, triptorelin, liraglutide, and other molecules. Insulin segment dominated the Indian peptides market in 2016. The growing incidence of diabetes in India are the key factors driving the growth of this segment.

On the basis of application, the Indian peptides market segmented into diabetes, cancer, cardiovascular disease (CVD), gynecological application, infectious diseases, osteoporosis, and other applications (acromegaly, multiple sclerosis, and hepatitis). Diabetes segment accounts for the largest segment and is also the fastest growing application segment in the market. The increasing prevalence and incidence of diabetes and rising awareness about the benefits of early diagnosis are the major factors driving the growth of this market.

Biocon Limited, Sun Pharmaceutical Industries Limited, Wokhardt Limited, Intas Pharmaceutical Limited, Cipla Limited, Emcure Pharmaceutical Limited, and Zydus Cadila have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. These companies have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

The Indian heparin market is expected to reach USD 170.2 million by 2022 from USD 127.8 million in 2016, at a CAGR of 4.9%. The growing incidence of coagulation disorders and government support for pharmaceutical companies are expected to drive the growth of this market.

The Indian heparin market is segmented by type. By type, the Indian heparin market is segmented into heparin sodium, enoxaparin sodium, fondaparinux, and dalteparin sodium. The enoxaparin sodium segment dominated the Indian peptides market in 2016. The growing incidence of coagulation disorder in India are the key factors driving the growth of this segment.

Availability of alternative drugs and the high degree of market consolidation are restraining the growth of the Indian peptides and heparin market. For example, the top players in this market are large & well established and enjoy a high degree of brand loyalty.

Emcure Pharmaceutical Pvt. Ltd., Cipla Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., and Biological E Limited have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. These companies have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

【レポートの目次】

1 Indian Peptides Market Overview (Page No. – 11)
1.1 Introduction
1.2 Indian Peptides Market Dynamics
1.2.1 Drivers
1.2.1.1 Rising Incidence of Diseases
1.2.1.2 Favorable Government Initiatives for the Pharmaceutical Sector
1.2.2 Restraint
1.2.2.1 Availability of Alternative Drugs
1.2.3 Opportunity
1.2.3.1 Patent Expiry of Blockbuster Peptides
1.2.4 Challenge
1.2.4.1 Regulatory and Pricing Issues

2 Indian Peptides Market, By Type (Page No. – 16)
2.1 Introduction
2.2 Insulin
2.2.1 Insulin Market : Companies With Pipeline Product
2.3 Teriparatide
2.3.1 Teriparatide Acetate Market: Companies With Pipeline Products
2.4 Liraglutide
2.5 Leuprolide Acetate
2.5.1 Leuprolide Acetate Market: Companies With Pipeline Products
2.6 Octreotide Acetate
2.7 Calcitonin-Salmon
2.8 Triptorelin
2.9 Eptifibatide
2.10 Glatiramer Acetate
2.11 Bivalirudin
2.12 Glucagon
2.13 Exenatide
2.13.1 Exenatide Market: Companeis With Pipeline Products
2.14 Other Molecules

3 Indian Peptides Market, By Application (Page No. – 32)
3.1 Introduction
3.2 Diabetes
3.3 Infectious Diseases
3.4 Cancer
3.5 Osteoporosis
3.6 Cardiology
3.7 Gynecology
3.8 Other Applications

4 Indian Peptides Market Share Analysis (Page No. – 36)

5 Indian Peptides Market Company Profiles (Page No. – 37)
(Business Overview, Products Offered)*
5.1 Biocon Limited
5.2 Sun Pharmaceutical Industries Ltd.
5.3 Wockhardt Ltd.
5.4 Intas Pharmaceuticals Ltd.
5.5 Cipla Limited
5.6 Emcure Pharmaceuticals Pvt. Ltd.
5.7 Zydus Cadila
5.8 Bharat Serum and Vaccines Limited
5.9 Natco Pharma Limited
5.10 Dr. Reddy’s Laboratories

*Details on Marketsandmarkets View, Business Overview, Products Offered Might Not Be Captured in Case of Unlisted Companies.

6 Indian Heparin Market Overview (Page No. – 53)
6.1 Introduction
6.2 Indian Heparin Market Dynamics
6.2.1 Drivers
6.2.1.1 Growing Incidence of Coagulation Disorders
6.2.1.2 Government Support for the Pharmaceutical Industry
6.2.2 Restraint
6.2.2.1 High Degree of Consolidation to Hinder Small Players From Entering the Market
6.2.3 Challenge
6.2.3.1 Regulatory and Pricing Issues

7 Indian Heparin Market, By Type (Page No. – 57)
7.1 Introduction
7.2 Enoxaparin Sodium
7.2.1 Enoxaparin Sodium Market: Companies With Pipeline Products
7.3 Heparin Sodium
7.4 Fondaparinux
7.4.1 Fondaparinux Market: Companies With Pipeline Products
7.5 Dalteparin Sodium
7.5.1 Dalteparin Sodium Market: Companies With Pipeline Products

8 Indian Heparin Market Share Analysis (Page No. – 63)

9 Indian Heparin Market Company Profiles (Page No. – 64)
(Business Overview, Products Offered)*
9.1 Cipla Ltd.
9.2 Emcure Pharmaceuticals Pvt. Ltd.
9.3 Gland Pharma Limited
9.4 Troikaa Pharmaceuticals Ltd.
9.5 Biological E Limited
9.6 Bharat Biotech
9.7 Samarth Life Sciences Pvt. Ltd.
9.8 VHB Life Sciences Limited
9.9 Celon Laboratories Pvt. Ltd.
9.10 United Biotech (P) Limited
*Details on Marketsandmarkets View, Business Overview, Products Offered Might Not Be Captured in Case of Unlisted Companies.
9.11 Author Details

List of Tables (45 Tables)

Table 1 Incidence of Cancer Cases in India, 2015 vs 2025
Table 2 Peptides and Their Alternatives
Table 3 Indian Peptides Market, By Type, 2016–2022 (USD Million)
Table 4 Insulin Market: Manufacturers and Brands
Table 5 Insulin Market: Key Players and Brands
Table 6 Teriparatide Acetate Market: Manufacturers and Brands
Table 7 Teriparatide Acetate Market: Key Players and Brands
Table 8 Liraglutide Market: Key Players and Brands
Table 9 Leuprolide Acetate Market: Manufacturers and Brands
Table 10 Leuprolide Acetate Market: Key Players and Brands
Table 11 Octreotide Acetate Market: Manufacturers and Brands
Table 12 Octreotide Acetate Market: Key Players and Brands
Table 13 Calcitonin-Salmon Market: Manufacturers and Brands
Table 14 Calcitonin-Salmon Market: Key Players and Brands
Table 15 Triptorelin Market: Manufacturers and Brands
Table 16 Triptorelin Market: Key Players and Brands
Table 17 Eptifibatide Market: Manufacturers and Brands
Table 18 Eptifibatide Market: Key Players and Brands
Table 19 Glatiramer Acetate Market: Manufacturers and Brands
Table 20 Glatiramer Acetate Market: Key Players and Brands
Table 21 Bivalirudin Market: Manufacturers and Brands
Table 22 Bivalirudin Market: Key Players and Brands
Table 23 Glucagon Market: Key Players and Brands
Table 24 Exenatide Market: Key Players and Brands
Table 25 Colistin Molecule: Manufactureres and Brands
Table 26 Colistin Market: Key Players and Brands
Table 27 Enalapril Molecule: Manufactureres and Brands
Table 28 Enalapril Market: Key Players and Brands
Table 29 Caspofungin: Manufactureres and Brands
Table 30 Caspofungin Market: Key Players and Brands
Table 31 Bortezomib: Manufactureres and Brands
Table 32 Bortezomib Market: Key Players and Brands
Table 33 Oxytocin: Manufacturers and Brands
Table 34 Oxytocin Market: Key Players and Brands
Table 35 Indian Peptides Market Size, By Application, 2016–2022 (USD Million)
Table 36 Incidence of Cancer Cases in India, 2015 vs 2025
Table 37 Indian Heparin Market, By Type, 2016–2022 (USD Million)
Table 38 Enoxaparin Sodium Market: Manufacturers and Brands
Table 39 Enoxaparin Sodium Market: Key Players and Brands
Table 40 Heparin Sodium Market: Manufacturers and Brands
Table 41 Heparin Sodium Market: Key Players and Brands
Table 42 Fondaparinux Market: Manufacturers and Brands
Table 43 Fondaparinux Market: Key Players and Brands
Table 44 Dalteparin Sodium Market: Manufacturers and Brands
Table 45 Dalteparin Sodium Market: Key Players and Brands



List of Figures (15 Figures)

Figure 1 Indian Peptides Market: Drivers, Restraints, Opportunities, and Challenges
Figure 2 Drug Approvals in India
Figure 3 Other Molecules: Market Share, 2016
Figure 4 Indian Peptides Market Share, By Key Player, 2016
Figure 5 Company Snapshot: Biocon Limited (2016)
Figure 6 Company Snapshot: Sun Pharmaceutical Industries Ltd (2016)
Figure 7 Company Snapshot: Wockhardt Ltd. (2016)
Figure 8 Company Snapshot: Intas Pharmaceuticals Ltd (2016)
Figure 9 Company Snapshot: Cipla Limited(2016)
Figure 10 Company Snapshot: Zydus Cadila (2016)
Figure 11 Company Snapshot: Natco Pharma Limited (2016)
Figure 12 Company Snapshot: Dr. Reddy’s Laboratories (2016)
Figure 13 Indian Heparin Market: Drivers, Restraints, and Challenges
Figure 14 Indian Heparin Market Share, By Key Player, 2016
Figure 15 Company Sanpshot: Cipla Ltd.

【レポートのキーワード】

ペプチド、ヘパリン、インド、インシュリン、テリパラチド、ロイプロリド、ロイプロリド、エキセナチド、カルシトニン、、ヘパリン・ナトリウム

★調査レポート[インドのペプチド及びヘパリン市場予測(~2022年)] ( Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022 / MAM-PH5511) 販売に関する免責事項
[インドのペプチド及びヘパリン市場予測(~2022年)] ( Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022 / MAM-PH5511) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆